As with all of NIH, the budget for NCATS is based on the fiscal year appropriation provided by Congress and the President. The process starts with the President’s Budget Request, which is usually released in February. The President's request typically is followed by appropriation hearings by Congress, which result in appropriation bills and reports. The final appropriation bill, if passed by Congress and signed by the President, provides NCATS with its budget for the fiscal year (October 1 through September 30).
NCATS tracks the status of its budget and provides relevant information below. The status of all appropriation bills also is available.
Future Fiscal Year: 2016
The President's budget is expected to be released on Monday, Feb. 2, 2015.
Current Fiscal Year: 2015
On Dec. 16, 2014, the President signed an appropriations bill (the “CRomnibus”) into law that funds NIH/NCATS through the end of the fiscal year. The law (P.L. 113-235) provides the following for NCATS:
"For carrying out section 301 and title IV of the PHS Act with respect to translational sciences, $635,230,000: Provided, That up to $9,835,000 shall be available to implement section 480 of the PHS Act, relating to the Cures Acceleration Network: Provided further, That at least $474,746,000 is provided to the Clinical and Translational Sciences Awards program."
Congressional Appropriations HearingsThe Congressional Appropriations Subcommittees on Labor, Health and Human Services, Education, and Related Agencies usually hold hearings on the NIH budget request.
Senate Hearing: April 2, 2014
House Hearing: March 26, 2014
The President released his FY 2015 budget on Tuesday, March 4, 2014. The FY 2015 budget request for NCATS is $657.471 million, an increase of $25.075 million over the FY 2014 enacted level. Requested changes reflect funding for new initiatives; additional competing research project grants over FY 2014; Small Business Innovation Research/Small Business Technology Transfer awards; expanded NCATS collaboration with the NIH Clinical Center; and redirected AIDS research funds to expand NIH support for research directed toward a cure for HIV.